Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Worsening Chronic Heart Failure”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Not applicableUnknownNCT04758429
What this trial is testing

International Multi-center Study to Validate an Early Warning Algorithm for Worsening Heart Failure

Who this might be right for
Chronic Heart Failure
Chronolife 552
Not applicableLooking for participantsNCT07284446
What this trial is testing

Depressive Symptoms, Cognitive Impairment, and Outcomes in Hospitalized Chronic Heart Failure Patients

Who this might be right for
Congestive Heart Failure ChronicCognitive Impairment, MildDepressive Symptoms Mild to Moderate in Severity
Lithuanian University of Health Sciences 300
Testing effectiveness (Phase 2)Study completedNCT01951638
What this trial is testing

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)

Who this might be right for
Heart Failure
Bayer 477
Not applicableTemporarily pausedNCT04589065
What this trial is testing

SCD for CRS in Congestive Heart Failure (CHF) (No Left Ventricular Assist Device)

Who this might be right for
Heart FailureChronic Systolic Heart FailureRenal Failure+1 more
Lenar Yessayan 10
Testing effectiveness (Phase 2)Study completedNCT01955694
What this trial is testing

Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone

Who this might be right for
Heart Failure
Bayer 72
Early research (Phase 1)Study completedNCT04908436
What this trial is testing

Learn How BAY94-8862 Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body in Adult Participants With Reduced Kidney Function and in Healthy Participants With Similar Age, Weight and Gender Distribution

Who this might be right for
Worsening Chronic Heart FailureChronic Kidney Disease
Bayer 33
Large-scale testing (Phase 3)Study completedNCT03036124
What this trial is testing

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure

Who this might be right for
Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)
AstraZeneca 4,744
Testing effectiveness (Phase 2)Ended earlyNCT00744341
What this trial is testing

Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure

Who this might be right for
Acute Decompensated Heart Failure; Renal Dysfunction
Solvay Pharmaceuticals 46
Very early researchUnknownNCT05566600
What this trial is testing

Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart Failure

Who this might be right for
Ischemic Heart FailureChronic Heart Failure
Help Therapeutics 32
Not applicableStudy completedNCT02133859
What this trial is testing

Adaptive Servo-ventilation Monitoring Study

Who this might be right for
Chronic Heart Failure
ResMed 40
Early research (Phase 1)Study completedNCT04881994
What this trial is testing

Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender Distribution

Who this might be right for
Worsening Chronic Heart FailureDiabetic Nephropathy
Bayer 27
Testing effectiveness (Phase 2)Ended earlyNCT05592275
What this trial is testing

LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

Who this might be right for
Heart FailureHeart Failure With Preserved Ejection Fraction
Eli Lilly and Company 332
Post-approval studies (Phase 4)Study completedNCT05658458
What this trial is testing

Learn How Well the Drug Vericiguat Works and How Safe it is Under Real World Conditions in Indian Participants After Worsening of a Long-term Heart Condition in Which the Left Side of the Heart Does Not Pump Blood as Well as it Should (Chronic Heart Failure With Reduced Ejection Fraction)

Who this might be right for
Chronic Heart Failure With Reduced Ejection FractionWorsening Heart Failure
Bayer 205
Not applicableStudy completedNCT04261452
What this trial is testing

Heart Failure Worsens Muscle Strength in COPD

Who this might be right for
COPDCHFMuscle Weakness
Mayron Faria de Oliveira 50
Not applicableNot Yet RecruitingNCT03836482
What this trial is testing

Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD

Who this might be right for
Acute on Chronic Systolic Congestive Heart FailureCardiorenal Syndrome
SeaStar Medical 20
Large-scale testing (Phase 3)Study completedNCT00071331
What this trial is testing

EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan

Who this might be right for
Congestive Heart Failure
Otsuka Pharmaceutical Development & Commercialization, Inc. 3,600
Large-scale testing (Phase 3)Study completedNCT02468232
What this trial is testing

Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction

Who this might be right for
Heart Failure With Reduced Ejection Fraction (HF-rEF)
Novartis Pharmaceuticals 225
Not applicableActive Not RecruitingNCT06632483
What this trial is testing

An Observational Study to Learn More About How Safe Vericiguat is and How Well it Works in Indian People With Chronic Heart Failure With Reduced Ejection Fraction and Worsening Chronic Heart Failure Under Real World Conditions

Who this might be right for
Chronic Heart Failure With Reduced Ejection FractionWorsening Chronic Heart Failure
Bayer 1,200
Testing effectiveness (Phase 2)Study completedNCT01951625
What this trial is testing

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)

Who this might be right for
Heart Failure
Bayer 456
Testing effectiveness (Phase 2)Study completedNCT01807221
What this trial is testing

Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone

Who this might be right for
Heart Failure
Bayer 1,066